X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5563) 5563
Book Review (964) 964
Publication (432) 432
Newsletter (64) 64
Conference Proceeding (13) 13
Book Chapter (12) 12
Magazine Article (4) 4
Newspaper Article (4) 4
Dissertation (2) 2
Trade Publication Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (4906) 4906
humans (4519) 4519
female (2840) 2840
triazoles - therapeutic use (2620) 2620
male (2186) 2186
triazoles - adverse effects (2071) 2071
middle aged (1779) 1779
adult (1621) 1621
triazoles - administration & dosage (1447) 1447
aged (1104) 1104
treatment outcome (1070) 1070
pharmacology & pharmacy (1041) 1041
triazoles - pharmacology (1029) 1029
animals (1023) 1023
voriconazole (935) 935
antifungal agents - therapeutic use (821) 821
breast neoplasms - drug therapy (777) 777
oncology (765) 765
nitriles - therapeutic use (744) 744
triazoles (634) 634
triazoles - pharmacokinetics (603) 603
adolescent (571) 571
antifungal agents - adverse effects (568) 568
nitriles - adverse effects (549) 549
drug therapy (513) 513
care and treatment (512) 512
analysis (499) 499
breast cancer (496) 496
dose-response relationship, drug (485) 485
therapy (477) 477
pyrimidines - therapeutic use (468) 468
antifungal agents - administration & dosage (460) 460
double-blind method (460) 460
safety (432) 432
infectious diseases (428) 428
tamoxifen (426) 426
drug therapy, combination (424) 424
letrozole (424) 424
pharmacokinetics (417) 417
nitriles - administration & dosage (415) 415
young adult (408) 408
postmenopausal women (405) 405
aromatase inhibitors (404) 404
cancer (401) 401
sitagliptin phosphate (401) 401
efficacy (400) 400
research (400) 400
administration, oral (376) 376
medicine & public health (372) 372
antifungal agents (368) 368
health aspects (367) 367
pyrimidines - adverse effects (359) 359
abridged index medicus (356) 356
aged, 80 and over (356) 356
microbiology (349) 349
rats (349) 349
anastrozole (346) 346
aromatase inhibitors - therapeutic use (345) 345
child (345) 345
drug interactions (345) 345
mice (338) 338
double-blind (337) 337
postmenopause (334) 334
antineoplastic agents, hormonal - therapeutic use (326) 326
diabetes mellitus, type 2 - drug therapy (326) 326
hematology (313) 313
time factors (299) 299
toxicology (298) 298
posaconazole (297) 297
mycoses (294) 294
drug administration schedule (293) 293
clinical trials (290) 290
fluconazole (288) 288
mycoses - drug therapy (288) 288
internal medicine (285) 285
triazoles - chemistry (285) 285
medicine, general & internal (284) 284
retrospective studies (284) 284
antifungal agents - pharmacokinetics (275) 275
tamoxifen - therapeutic use (275) 275
immunology (270) 270
aspergillosis (267) 267
breast neoplasms - pathology (267) 267
aromatase inhibitors - adverse effects (266) 266
endocrinology & metabolism (266) 266
pyrazines - therapeutic use (265) 265
pyrimidines - administration & dosage (257) 257
randomized controlled trials as topic (257) 257
risk factors (255) 255
itraconazole (252) 252
triazoles - toxicity (251) 251
aspergillosis - drug therapy (250) 250
amphotericin-b (248) 248
clinical trials as topic (244) 244
pharmacology (242) 242
prospective studies (242) 242
transplantation (238) 238
benzoates - therapeutic use (227) 227
obstetrics & gynecology (227) 227
toxicity (227) 227
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5418) 5418
German (52) 52
Japanese (50) 50
Spanish (41) 41
French (36) 36
Italian (10) 10
Chinese (9) 9
Russian (9) 9
Dutch (7) 7
Hungarian (5) 5
Swedish (3) 3
Polish (2) 2
Turkish (2) 2
Czech (1) 1
Danish (1) 1
Norwegian (1) 1
Persian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10047, pp. 881 - 890
Summary Background Major depressive disorder is one of the most common mental disorders in children and adolescents. However, whether to use pharmacological... 
Internal Medicine | TRIALS | MEDICINE, GENERAL & INTERNAL | ACCEPTABILITY | MENTAL-HEALTH-CARE | TRENDS | GUIDELINES | Mianserin - adverse effects | Triazoles - administration & dosage | Triazoles - adverse effects | Humans | Citalopram - adverse effects | Sertraline - adverse effects | Venlafaxine Hydrochloride - adverse effects | Imipramine - administration & dosage | Paroxetine - adverse effects | Mianserin - analogs & derivatives | Paroxetine - administration & dosage | Desipramine - adverse effects | Nortriptyline - administration & dosage | Nortriptyline - adverse effects | Mianserin - administration & dosage | Child | Fluoxetine - adverse effects | Depressive Disorder, Major - drug therapy | Clomipramine - administration & dosage | Duloxetine Hydrochloride - adverse effects | Double-Blind Method | Drug Administration Schedule | Treatment Outcome | Clomipramine - adverse effects | Evidence-Based Medicine | Desipramine - administration & dosage | Randomized Controlled Trials as Topic | Venlafaxine Hydrochloride - administration & dosage | Citalopram - administration & dosage | Confounding Factors (Epidemiology) | Sertraline - administration & dosage | Adolescent | Amitriptyline - adverse effects | Bayes Theorem | Fluoxetine - administration & dosage | Duloxetine Hydrochloride - administration & dosage | Antidepressive Agents - administration & dosage | Antidepressive Agents - adverse effects | Research Design | Amitriptyline - administration & dosage | Imipramine - adverse effects | Psychological aspects | Medical colleges | Neurosciences | Drugs and youth | Rankings | Comparative analysis | Child psychopathology | Major depressive disorder | Antidepressants, Tricyclic | Pediatric pharmacology | Mental illness | Studies | Teenagers | Mental depression | Antidepressants | Meta-analysis | Children & youth | Index Medicus | Abridged Index Medicus
Journal Article
Archives of Toxicology, ISSN 0340-5761, 12/2018, Volume 92, Issue 12, pp. 3549 - 3564
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2009, Volume 360, Issue 7, pp. 679 - 691
This large trial tested the effect of adding zoledronic acid to adjuvant endocrine treatment (goserelin plus tamoxifen or anastrozole) in premenopausal women... 
RECEIVING ADJUVANT LETROZOLE | MULTIPLE-MYELOMA | OVARIAN ABLATION | BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS | MEDICINE, GENERAL & INTERNAL | BONE LOSS | SOLID TUMORS | TAMOXIFEN | DELTA-T-CELLS | POSTMENOPAUSAL WOMEN | AUSTRIAN BREAST | Breast Neoplasms - surgery | Triazoles - adverse effects | Follow-Up Studies | Humans | Middle Aged | Receptors, Estrogen - analysis | Antineoplastic Agents, Hormonal - adverse effects | Aromatase Inhibitors - adverse effects | Antineoplastic Agents, Hormonal - therapeutic use | Diphosphonates - therapeutic use | Adult | Female | Chemotherapy, Adjuvant | Imidazoles - therapeutic use | Drug Therapy, Combination | Goserelin - therapeutic use | Aromatase Inhibitors - therapeutic use | Diphosphonates - adverse effects | Triazoles - therapeutic use | Bone Density Conservation Agents - adverse effects | Premenopause | Imidazoles - adverse effects | Bone Density Conservation Agents - therapeutic use | Breast Neoplasms - drug therapy | Disease-Free Survival | Estrogen Antagonists - therapeutic use | Tamoxifen - therapeutic use | Estrogen Antagonists - adverse effects | Tamoxifen - adverse effects | Nitriles - adverse effects | Nitriles - therapeutic use | Zoledronic acid | Care and treatment | Usage | Breast cancer | Health aspects | Function tests (Medicine) | Chemotherapy | Acids | Womens health | Menopause | Colorectal cancer | Cytotoxicity | Radiation therapy | Cancer therapies | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 20, pp. 1925 - 1936
Journal Article
Diabetologia, ISSN 0012-186X, 12/2013, Volume 56, Issue 12, pp. 2582 - 2592
The aim of this work was to evaluate the efficacy and safety of canagliflozin vs placebo and sitagliptin in patients with type 2 diabetes who were being... 
Sodium glucose co-transporter 2 (SGLT2) inhibitor | Medicine & Public Health | Human Physiology | Canagliflozin | Metabolic Diseases | Internal Medicine | Sitagliptin | Metformin | Type 2 diabetes mellitus | GLIPIZIDE | ADD-ON | SULFONYLUREA | DAPAGLIFLOZIN | MELLITUS | INADEQUATE GLYCEMIC CONTROL | DIET | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | 52-WEEK | INHIBITOR | Blood Pressure | Triazoles - administration & dosage | Triazoles - adverse effects | Thiophenes - adverse effects | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Pyrazines - administration & dosage | Glycated Hemoglobin A - drug effects | Body Weight - drug effects | Lipids | Male | Thiophenes - administration & dosage | Metformin - adverse effects | Hypoglycemic Agents - administration & dosage | Aged, 80 and over | Female | Metformin - administration & dosage | Sitagliptin Phosphate | Drug Therapy, Combination | Glucosides - adverse effects | Fasting | Treatment Outcome | Blood Glucose - drug effects | Diabetes Mellitus, Type 2 - blood | Glucosides - administration & dosage | Adolescent | Pyrazines - adverse effects | Aged | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Care and treatment | Body weight | Glucose | Comparative analysis | Dextrose | Index Medicus
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 09/2012, Volume 56, Issue 9, pp. 4793 - 4799
Journal Article
Annals of Oncology, ISSN 0923-7534, 2013, Volume 24, Issue 2, pp. 398 - 405
Journal Article
Journal Article